FST-100 in the Treatment of Acute Viral Conjunctivitis

Completed · Phase 2

Conditions studied: Acute Viral Conjunctivitis

In brief

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conjunctivitis.

Key facts

Study ID

NCT01461954

Run by

Shire

People needed

132

Starts

2013-05-17

Expected to finish

2014-03-10

Last updated by the study team

2021-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have a clinical diagnosis of suspected acute viral conjunctivitis in at least one eye

You may not qualify if…

• Have a known sensitivity to any of the components of FST-100 or FST-100 vehicle

Where it is running

• Ora Clinical Site — Andover, Massachusetts, United States
• Hospital São Paulo/Federal University of São Paulo (UNIFESP) — São Paulo, Brazil

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.